M4MM
Psychedelics Market Set to Reach $22.6 Billion by 2033, Report Finds
NEW YORK – A recent report by Research and Markets reveals the current global psychedelic drugs market is valued at $7.4 billion and is projected to hit $22.6 billion by 2033, exhibiting a substantial compound ...
High Tide Enters German Medical Cannabis Market with Remexian Majority Stake Acquisition
CALGARY – High Tide Inc., a leading Canadian Cannabis retailer, announced its strategic entry into Germany’s medical Cannabis market through a 51% acquisition of Remexian Pharma GmbH, a Frankfurt-based pharmaceutical wholesaler. The deal, valued at ...
Germany’s Medical Cannabis Imports Hit Record in Q2 2025, Sparking Debate Over Misuse
BERLIN – Germany’s medical Cannabis market continues to set records, with imports reaching 43.3 tons in the second quarter of 2025, according to data from the Federal Institute for Drugs and Medical Devices (BfArM). This ...
Trump Administration Proposes Elimination of Federal Protections for State Medical Cannabis Programs
LOS ANGELES- The Trump administration's fiscal year 2026 budget proposal includes the removal of a longstanding provision that prohibits the Department of Justice (DOJ) from using federal funds to interfere with state-legal medical cannabis programs. ...
Psychedelic Drugs Market Projects Significant Growth Through 2029
LOS ANGELES- The global psychedelic drugs market is projected to experience substantial growth, with estimates indicating an increase from $6.39 billion in 2025 to $11.93 billion by 2029, reflecting a compound annual growth rate (CAGR) ...
Village Farms Completes Divestiture of Fresh Produce Business to Focus on Cannabis
LOS ANGELES- Village Farms International Inc. has finalized the transaction to privatize its fresh produce operations, marking a strategic shift to concentrate on its cannabis ventures. The deal, completed on May 30, 2025, involves the ...
Massachusetts House Approves Cannabis Oversight Reform Bill
LOS ANGELES- The Massachusetts House of Representatives has unanimously passed legislation aimed at restructuring the state's cannabis regulatory framework. The bill, designated as H 4187, seeks to address administrative challenges and enhance oversight within the ...
Psychedelics Market Set to Reach $22.6 Billion by 2033, Report Finds
NEW YORK – A recent report by Research and Markets reveals the current global psychedelic drugs market is valued at $7.4 billion and is projected to hit $22.6 billion by 2033, exhibiting a substantial compound ...
High Tide Enters German Medical Cannabis Market with Remexian Majority Stake Acquisition
CALGARY – High Tide Inc., a leading Canadian Cannabis retailer, announced its strategic entry into Germany’s medical Cannabis market through a 51% acquisition of Remexian Pharma GmbH, a Frankfurt-based pharmaceutical wholesaler. The deal, valued at ...
Germany’s Medical Cannabis Imports Hit Record in Q2 2025, Sparking Debate Over Misuse
BERLIN – Germany’s medical Cannabis market continues to set records, with imports reaching 43.3 tons in the second quarter of 2025, according to data from the Federal Institute for Drugs and Medical Devices (BfArM). This ...
ACT LAB Expands Operations with Acquisition of Florida Lab Assets from Green Scientific
LOS ANGELES-- ACT LAB, a lab testing company in the legal cannabis and hemp markets, has recently announced its successful regulatory approval and completion of the acquisition of Florida lab operations and associated assets from ...
Cannabis Companies Confront Operational Challenges Amidst Severe Weather
LOS ANGELES-- As severe weather conditions persist, cannabis companies spanning from Northern California to South Florida are grappling with new operational obstacles. The strain on power grids and the aftermath of historic flooding in parts ...
Aleafia Health and Red White & Bloom Brands Terminate Merger Amid Debenture Dispute
TORONTO — The anticipated merger between Canadian cannabis company Aleafia Health and U.S. multistate cannabis operator Red White & Bloom Brands has been called off, according to an announcement made by the companies. The proposed ...
Compass Pathways’ Psilocybin Treatment Shows Promise for Depression
LONDON-- London-based mental health care company, Compass Pathways (Nasdaq: CMPS), announced encouraging outcomes from a phase 2 clinical trial investigating the efficacy of its synthetic psilocybin treatment, COMP360, in combination with daily SSRI antidepressants for ...
Study: Cannabis Use Enhances ‘Runner’s High’ During Exercise
LOS ANGELES-Recent research published in the journal Cannabis and Cannabinoid Research has shed light on an intriguing association between cannabis use and an enhanced running experience. According to the study's data, individuals who used cannabis ...
Canadian Cannabis Entrepreneurs Turn to Micro-Cultivation to Tackle Oversupply
TORONTO-- In response to a surplus of cannabis and declining prices within the Canadian cannabis industry, cannabis entrepreneurs are increasingly embracing smaller micro-cultivation facilities as a means to reduce costs and produce higher-quality cannabis. This ...
Week In Review: Cannabis & Psychedelic Sectors Diverge: TerrAscend Leads Cannabis Stocks, Canopy Growth Struggles, Awakn & Cybin Forge Ahead
LOS ANGELES- In the fast-paced world of cannabis and psychedelics, last week's developments & ''liquidity events'' have left investors and industry experts alike eagerly observing the unfolding landscape. These events have showcased both encouraging victories ...
Ohio Adds Irritable Bowel Syndrome to Medical Cannabis Qualifying Conditions
LOS ANGELES-- On July 12, the State Medical Board of Ohio announced its decision to include irritable bowel syndrome (IBS) in the state's list of qualifying conditions for medical cannabis. However, the board rejected the ...
Red Lake Nation to Open Minnesota’s First Native American Adult-Use Cannabis Store
LOS ANGELES --In a significant development for Minnesota's cannabis industry, the Red Lake Nation has voted to allow NativeCare Dispensary, an existing tribal medical cannabis dispensary, to commence sales to individuals aged 21 and older ...
Cannabis Industry Seeks Relief from Unfair Tax Burden of 280E
In a nod to the historic Boston Tea Party of 1773, cannabis company MariMed recently held the 'Boston 280E THC Party' in Boston Harbor, a unique event designed to protest Tax Code 280E. CEO and ...
North Carolina Medical Cannabis Legalization Bill Faces Republican Opposition
LOS ANGELES-- Efforts to legalize medical cannabis in North Carolina have hit a roadblock, as the bill that gained bipartisan support in the state Senate earlier this year has been deemed unlikely to pass in ...
Michigan Civil Service Commission Votes to Lift Cannabis Drug Test Ban for Most State Employees
LOS ANGELES-- In a unanimous decision, the Michigan Civil Service Commission has voted to eliminate the prohibition on hiring most state employees who fail pre-employment drug tests for cannabis, as reported by MLive. This move ...
TerrAscend Secures $25 Million Commercial Loan to Reduce Debt and Lower Interest Expenses
LOS ANGELES-- TerrAscend Corp., a cannabis operator in North America, has successfully closed a commercial loan of $25 million with Stearns Bank. The loan proceeds will primarily be used to pay down existing debt with ...
Ukraine Parliament Gives Initial Approval to Medical Cannabis Legalization Proposal
KYIV-- The Ukraine Parliament has taken a significant step towards the legalization of medical cannabis by granting initial approval to a proposed legislation. The bill, which still requires potential amendments and a second reading, must ...
Record-Breaking Cannabis Sales in Massachusetts Reach $151.8 Million in June
BOSTON-- Massachusetts witnessed an extraordinary surge in cannabis sales during the month of June, with total transactions reaching a remarkable $151.8 million, as reported by state figures. This impressive figure consists of $132.8 million in ...
